| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |